2023 was a troublesome calendar year to the biopharma marketplace, with quite a few providers downsizing and restructuring their workforces to remain afloat. There are actually signs of recovery, as mergers and acquisitions picked up through the pharmaceutical and existence sciences marketplace during the latter Element of 2023 and have https://sites.google.com/view/bio-sites/blog